FRANCESC SOLE

Citada per

	Totes	Des de 2019
Citacions	17792	7338
Índex h	60	34
Índex i10	211	107

1700

850

425

1275

199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202456 38 46 50 58 52 90 103 140 190 241 241 284 286 346 301 421 586 674 999 918 983 1051 1032 962 887 1041 1280 1403 1607 1104

Accés públic

Mostra-ho tot

115 articles

3 articles

disponibles

no disponibles

Es basa en els requisits de les agències que proporcionen el finançament

Coautors

Lurdes ZamoraCoordinadora de la Unitat de Biologia Molecular, Servei Laboratori Hematologia, Institut Català d’Oncologia - Institut Josep CarrerasCorreu electrònic verificat a iconcologia.net
Vera AdemaInstructorCorreu electrònic verificat a mdanderson.org
jarek maciejewskiCorreu electrònic verificat a ccf.org
Isabel GranadaCitogenetista, Institut Català d'OncologiaCorreu electrònic verificat a iconcologia.net
Juan Cruz CigudosaScientific Director, NIMGenetics. Molecular Cytogenetics, CNIOCorreu electrònic verificat a nimgenetics.com
María José Calasanz (orcid.org/0000-...Professor of Genetics. Universidad de NavarraCorreu electrònic verificat a unav.es
Leonor ArenillasHematologist, Hospital del Mar, BarcelonaCorreu electrònic verificat a parcdesalutmar.cat
Pamela AchaJosep Carreras Leukaemia Research InstituteCorreu electrònic verificat a carrerasresearch.org
MARÍA DÍEZ CAMPELOMédico Adjunto, Servicio de Hematología, Hospital Universitario de SalamancaCorreu electrònic verificat a usal.es
Guillermo Sanz SantillanaHematology Department, Hospital La Fe, Valencia, SpainCorreu electrònic verificat a gva.es
- SalarResearches in AI, RoboticsCorreu electrònic verificat a g.uporto.pt
Jose Maria Ribera SantasusanaInstitut de Recerca Contra la Leucemia Josep CarrerasCorreu electrònic verificat a iconcologia.net
Andrés JerezUniversidad de MurciaCorreu electrònic verificat a um.es
Mikkael SekeresProfessor of Medicine, Sylvester Comprehensive Cancer Center, University of MiamiCorreu electrònic verificat a med.miami.edu
Jose A Martinez-Climent, MD, PhDCIMA, Universidad de NavarraCorreu electrònic verificat a unav.es
Javier Grau CatICO-Badalona. Hospital Universitari Germans Trias i PujolCorreu electrònic verificat a iconcologia.net
MªPilar Garcia MuretDermatologist, Senior Consultant of Hospital de la Santa Creu i Sant Pau. Professor, Universitat Autònoma de Barcelona School of Medicine.Correu electrònic verificat a santpau.cat
Puigdecanet, EulàliaUniversitat de Vic - Universitat Central de CatalunyaCorreu electrònic verificat a umedicina.cat
michael pfeilstoecker3rd Med Dept, Hanusch Hospital, Vienna,AustriaCorreu electrònic verificat a oegk.at
Mariana Belen Gonzalez HernandezKeiser UniversityCorreu electrònic verificat a student.keiseruniversity.edu

Segueix

FRANCESC SOLE

Institut de Recerca contra la Leucemia Josep Carreras

Correu electrònic verificat a carrerasresearch.org

Hematología Genética


Títol Ordena per cites Ordena per any Ordena per títol	Citada per Citada per	Any
Revised international prognostic scoring system for myelodysplastic syndromes PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012	3454	2012
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international … J Schanz, H Tüchler, F Solé, M Mallo, E Luno, J Cervera, I Granada, ... Journal of clinical oncology 30 (8), 820-829, 2012	848	2012
Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma V Fernàndez, O Salamero, B Espinet, F Solé, C Royo, A Navarro, ... Cancer research 70 (4), 1408-1418, 2010	546	2010
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020	508	2020
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype A Mozos, C Royo, E Hartmann, D De Jong, C Baró, A Valera, K Fu, ... haematologica 94 (11), 1555, 2009	480	2009
Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022	478	2022
Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes Solé, Espinet, Sanz, Cervera, Calasanz, Luño, Prieto, Granada, ... British journal of haematology 108 (2), 346-356, 2000	390	2000
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, ... Leukemia 22 (3), 487-495, 2008	321	2008
Cytogenetic risk stratification in chronic myelomonocytic leukemia E Such, J Cervera, D Costa, F Solé, T Vallespí, E Luño, R Collado, ... Haematologica 96 (3), 375, 2011	309	2011
Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients C Besses, F Cervantes, A Pereira, L Florensa, F Sole, ... Leukemia 13 (2), 150-154, 1999	303	1999
Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes F Sole, E Luno, C Sanzo, B Espinet, GF Sanz, J Cervera, MJ Calasanz, ... Haematologica 90 (9), 1168-1178, 2005	295	2005
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group M Salido, C Baró, D Oscier, K Stamatopoulos, J Dierlamm, E Matutes, ... Blood, The Journal of the American Society of Hematology 116 (9), 1479-1488, 2010	231	2010
Guidance for laboratories performing molecular pathology for cancer patients IA Cree, Z Deans, MJL Ligtenberg, N Normanno, A Edsjö, E Rouleau, ... Journal of clinical pathology 67 (11), 923-931, 2014	225	2014
Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations MJ Calasanz, JC Cigudosa, MD Odero, C Ferreira, MT Ardanaz, A Fraile, ... Genes, Chromosomes and Cancer 18 (2), 84-93, 1997	221	1997
Analysis of the IgV_H somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical … P Algara, MS Mateo, M Sanchez-Beato, M Mollejo, IC Navas, L Romero, ... Blood, The Journal of the American Society of Hematology 99 (4), 1299-1304, 2002	209	2002
Role of casein kinase 1A1 in the biology and targeted therapy of del (5q) MDS RK Schneider, V Adema, D Heckl, M Järås, M Mallo, AM Lord, LP Chu, ... Cancer cell 26 (4), 509-520, 2014	207	2014
Time-dependent changes in mortality and transformation risk in MDS M Pfeilstöcker, H Tuechler, G Sanz, J Schanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 128 (7), 902-910, 2016	188	2016
Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes M Bersanelli, E Travaglino, M Meggendorfer, T Matteuzzi, C Sala, ... Journal of Clinical Oncology 39 (11), 1223-1233, 2021	173	2021
Molecular heterogeneity in MCL defined by the use of specificV_H genes and the frequency of somatic mutations FI Camacho, P Algara, A Rodrıguez, E Ruız-Ballesteros, M Mollejo, ... Blood, The Journal of the American Society of Hematology 101 (10), 4042-4046, 2003	173	2003
Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study AP Losada, M Wessman, M Tiainen, AH Hopman, HF Willard, F Sole, ...	172	1991

En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.

Articles 1–20

Cites per any

Cites duplicades

Cites combinades

Addició de coautorsCoautors

Segueix

Citada per

Coautors